Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Technology Transfers To Least-Developed Countries Often Not An Option - IFPMA Report

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - The transfer of technology developed by high-end research-based pharmaceutical companies to operations in developing countries is increasingly common, but rarely simple
Advertisement

Related Content

U.S. AIDS Assistance Unable To Transfer To Local Ownership In Emerging Markets Like Africa
BMS Launches Pilot Program With WHO In Five African Countries
BMS Launches Pilot Program With WHO In Five African Countries
New Vaccine Partnership With GSK Could Act As Lifeline For Chinese Biotech Firm Neptunus, Which Has Been Trapped In Troubled Financial Seas
AIDS Drugs Pricing Plans For Poor Nations May Preclude Legislation
AIDS Drugs Pricing Plans For Poor Nations May Preclude Legislation
Advertisement
UsernamePublicRestriction

Register

SC077463

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel